New scope-based procedure may offer relief for chronic heartburn sufferers

NCT ID NCT05570448

First seen Mar 16, 2026 · Last updated May 08, 2026 · Updated 15 times

Summary

This study tests a new procedure called Anti-Reflux Endoscopic Therapy using argon plasma coagulation (ARAT) for people with chronic gastroesophageal reflux disease (GERD). Participants must have had heartburn or acid reflux at least twice a week for 6 months and have a positive pH test. The goal is to see if this treatment improves quality of life and reduces the need for daily acid-reducing medications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRO ESOPHAGEAL REFLUX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kansas City VA Hospital

    RECRUITING

    Kansas City, Missouri, 64128, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.